Goreisan Prevents Brain Edema after Cerebral Ischemic Stroke by Inhibiting Aquaporin 4 Upregulation in Mice

Autor: Takashi Egawa, Yoshihiko Nakamura, Hiroyasu Ishikura, Chisa Nishigami, Hidetoshi Kamimura, Koji Tominaga, Kazunori Sano, Keiichi Irie, Yuta Yamashita, Kenichi Mishima, Koichi Matsuo, Takayuki Myose, Yutaka Shigemori, Takafumi Nakano
Rok vydání: 2018
Předmět:
Zdroj: Journal of Stroke and Cerebrovascular Diseases. 27:758-763
ISSN: 1052-3057
DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.010
Popis: Background Aquaporin 4 (AQP4) is a water-selective transport protein expressed in astrocytes throughout the central nervous system. AQP4 level increases after cerebral ischemia and results in ischemic brain edema. Brain edema markedly influences mortality and motor function by elevating intracranial pressure that leads to secondary brain damage. Therefore, AQP4 is an important target to improve brain edema after cerebral ischemia. The Japanese herbal Kampo medicine, goreisan, is known to inhibit AQP4 activity. Here, we investigated whether goreisan prevents induction of brain edema by cerebral ischemia via AQP4 using 4-hour middle cerebral artery occlusion (4h MCAO) mice. Methods Goreisan was orally administered at a dose of 500 mg/kg twice a day for 5 days before MCAO. AQP4 expression and motor coordination were measured by Western blotting and rotarod test, respectively. Results Brain water content of 4h MCAO mice was significantly increased at 24 hours after MCAO. Treatment with goreisan significantly decreased both brain water content and AQP4 expression in the ischemic brain at 24 hours after MCAO. In addition, treatment with goreisan alleviated motor coordination deficits at 24 hours after MCAO. Conclusions The results of this study suggested that goreisan may be a useful new therapeutic option for ischemic brain edema.
Databáze: OpenAIRE